✦ LIBER ✦

Energy metabolism defects in Huntington's disease and effects of coenzyme Q10

✍ Scribed by Walter J. Koroshetz; Bruce G. Jenkins; Bruce R. Rosen; Dr M. Flint Beal

Publisher: John Wiley and Sons
Year: 1997
Tongue: English
Weight: 516 KB
Volume: 41
Category: Article
ISSN: 0364-5134
DOI: 10.1002/ana.410410206

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Assessment of coenzyme q10 tolerability

Assessment of coenzyme q10 tolerability in huntington's disease

✍ Dr. A. Feigin; K. Kieburtz; P. Como; C. Hickey; D. Abwender; C. Zimmerman; K. St 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 273 KB

## Abstract We performed a 6‐month open‐label trial to evaluate the tolerability and efficacy of coenzyme Q10 (CoQ) in 10 patients with Huntington's disease (HD), Subjects were evaluated at baseline, 3 months, and 6 months using the HD Rating Scale (HDRS), the HD Functional Capacity Scale (HDFCS),

Safety and tolerability of high-dosage c

Safety and tolerability of high-dosage coenzyme Q10 in Huntington's disease and healthy subjects

✍ The Huntington Study Group Pre2CARE Investigators 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 64 KB 👁 1 views

Abnormal in vivo skeletal muscle energy

Abnormal in vivo skeletal muscle energy metabolism in Huntington's disease and dentatorubropallidoluysian atrophy

✍ R. Lodi; A. H. V. Schapira; D. Manners; P. Styles; N. W. Wood; D. J. Taylor; T. 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 152 KB 👁 2 views

Brain energy metabolism and dopaminergic

Brain energy metabolism and dopaminergic function in Huntington's disease measured in vivo using positron emission tomography

✍ Dr. K. L. Leenders; R. S. J. Frackowiak; N. Quinn; C. D. Marsden 📂 Article 📅 1986 🏛 John Wiley and Sons 🌐 English ⚖ 549 KB

A 48-year-old man with typical Huntington's disease was investigated with computed tomography (CT) and positron emission tomography. Regional cerebral blood flow, oxygen extraction, oxygen and glucose utiIisation, L-Dopa uptake, and dopamine (D2) receptor binding were measured using several positron

Effects of rivastigmine on motor and cog

Effects of rivastigmine on motor and cognitive impairment in Huntington's disease

✍ Marina de Tommaso; Nicola Specchio; Vittorio Sciruicchio; Olimpia Difruscolo; Lu 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 192 KB 👁 1 views

## Abstract To evaluate the efficacy of rivastigmine on motor and cognitive impairment in Huntington's disease (HD), we carried out a prospective, open‐label, randomized, controlled study. Twenty‐one HD patients were enrolled: 14 were randomly sorted into medication and 7 to no‐treatment groups. Cl

The reduced form of coenzyme Q10 mediate

The reduced form of coenzyme Q10 mediates distinct effects on cholesterol metabolism at the transcriptional and metabolite level in SAMP1 mice

✍ Constance Schmelzer; Jürgen G. Okun; Dorothea Haas; Keiichi Higuchi; Jinko Sawas 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 351 KB 👁 1 views

Studies in humans and mice indicate a role for coenzyme Q(10) (CoQ(10)) in gene expression. To analyze this function in relation to metabolism, SAMP1 mice were supplemented with the reduced (ubiquinol) or oxidized (ubiquinone) form of CoQ(10) (500 mg/kg BW/d) for 14 months. Microarray analyses in li